New insights and challenges in microscopic colitis

Therapeutic Advances in Gastroenterology

Volumn 8, Issue 1, 2015, Pages 37-47

  Ohlsson, Bodil ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ageing; irritable bowel syndrome; lifestyle factors; microscopic colitis; smoking

Indexed keywords

ANTIDIARRHEAL AGENT; AUTOANTIBODY; BUDESONIDE; COLESTYRAMINE; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE 4; ESTROGEN; FIBRONECTIN; GELATINASE B; HLA DQ ANTIGEN; IMMUNOMODULATING AGENT; IRRITANT AGENT; LAMININ; LOPERAMIDE; PROGESTERONE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL PAIN; ALCOHOL CONSUMPTION; AUTOIMMUNITY; CELIAC DISEASE; CLINICAL FEATURE; COLLAGENOUS COLITIS; COLON BIOPSY; COLON MUCOSA; COLON RESECTION; COLONOSCOPY; COMORBIDITY; CONSTIPATION; CROHN DISEASE; DIABETES MELLITUS; DIARRHEA; GENETIC PREDISPOSITION; HEALTH CARE COST; HEALTH INSURANCE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; ILEOSTOMY; INCIDENCE; INTESTINE FLORA; INTESTINE MUCOSA; LAMINA PROPRIA; LYMPHOCYTIC COLITIS; LYMPHOCYTIC INFILTRATION; MICROSCOPIC COLITIS; OVERPRESCRIPTION; PATHOGENESIS; PRESCRIPTION; QUALITY OF LIFE; REMISSION; REVIEW; RHEUMATOID ARTHRITIS; SMOKING; THYROID DISEASE; ULCERATIVE COLITIS;

EID: 84919469266     PISSN: 1756283X     EISSN: 17562848     Source Type: Journal    
DOI: 10.1177/1756283X14550134     Document Type: Review

References (95)

1. Abdo A. Zetler P. Halparin L. (2001) Familial microscopic colitis. Can J Gastroenterol 15: 341–343.
2. Baert F. Schmit A. D'Haens G. Dedeurwaerdere F. Louis E. Cabooter M. et al. (2002) Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 122: 20–25.
3. Beaugerie L. Pardi D. (2005) Review article: drug-induced microscopic colitis – proposal for a scoring system and review of the literature. Aliment Pharmacol Ther 22: 277–284.
4. Boekema P. van Dam van Isselt E. Bots M. Smout A. (2001) Functional bowel symptoms in a general Dutch population and associations with common stimulants. Neth J Med 59: 23–30.
5. Bohr J. Tysk C. Eriksson S. Abrahamsson H. Järnerot G. (1996) Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 39: 846–851.
6. Bonderup O. Hansen J. Birket-Smith L. Vestergaard V. Teglbjaerg P. Fallingborg J. (2003) Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut 52: 248–251.
7. Bonderup O. Hansen J. Teglbjaerg P. Christensen L. Fallingborg J. (2009) Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. Gut 58: 68–72.
8. Bonner G. Petras R. Cheong D. Grewal I. Breno S. Ruderman W. (2000) Short- and long-term follow-up of treatment for lymphocytic and collagenous colitis. Inflamm Bowel Dis 6: 85–91.
9. Braskén P. (1991) Healing of experimental colon anastomosis. Eur J Surg Suppl 566: 1–51.
10. Carmack S. Lash R. Gulizia J. Genta R. (2009) Lymphocytic disorders of the gastrointestinal tract: a review for the practicing pathologist. Adv Anat Pathol 16: 290–306.
11. Carpenter H. Tremaine W. Batts K. Czaja A. (1992) Sequential histologic evaluations in collagenous colitis. Correlations with disease behavior and sampling strategy. Dig Dis Sci 37: 1903–1909.
12. Chan J. Tersmette A. Offerhaus G. Gruber S. Bayless T. Giardiello F. (1999) Cancer risk in collagenous colitis. Inflamm Bowel Dis 15: 40–43.
13. Chande N. McDonald J. Macdonald J. (2008) Interventions for treating collagenous colitis. Cochrane Database Syst Rev CD003575.
14. Chassany O. Michaux A. Bergmann J. (2000) Drug-induced diarrhoea. Drug Saf 22: 53–72.
15. Drossman D. Corazziari E. Talley N. Thompson W. Whitehead W. (eds) (2006) Rome III: The Functional Gastrointestinal Disorders. Third edition. McLean, VA: Degnon.
16. Erim T. Alazmi W. O'Loughlin C. Barkin J. (2003) Collagenous colitis associated with Clostridium difficile: a cause effect? Dig Dis Sci 48: 1374–1375.
17. Fernandez-Banares F. Esteve M. Espinos J. Rosinach M. Forné M. Salas A. et al. (2007) Drug consumption and the risk of microscopic colitis. Am J Gastroenterol 102: 324–330.
18. Fernandez-Banares F. Esteve M. Farre C. Salas A. Alsina M. Casalots J. et al. (2005) Predisposing HLA-DQ2 and HLA-DQ8 haplotypes of coeliac disease and associated enteropathy in microscopic colitis. Eur J Gastroenterol Hepatol 17: 1333–1338.
19. Fernandez-Banares F. Esteve M. Salas A. Forne T. Espinos J. Martin-Comin J. et al. (2001) Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea. Dig Dis Sci 46: 2231–2238.
20. Fernandez-Banares F. Salas A. Esteve M. Pardo L. Casalots J. Forne M. et al. (2011) Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: a population-based study. Inflamm Bowel Dis 17: 1015–1020.
21. Fernandez-Banares F. Salas A. Forne M. Esteve M. Espinos J. Viver J. (1999) Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol 94: 418–423.
22. Fine K. Lee E. (1998) Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis. Gastroenterology 114: 29–36.
23. Flejou J. Grimaud J. Molas G. Baviera E. Potet F. (1984) Collagenous colitis. Ultrastructural study and collagen immunotyping of four cases. Arch Pathol Lab Med 108: 977–982.
24. Fujiwara Y. Kubo M. Kohata Y. Machida H. Okazaki H. Yamagami H. et al. (2011) Cigarette smoking and its association with overlapping gastroesophageal reflux disease, functional dyspepsia, or irritable bowel syndrome. Intern Med, 50: 2443–2447.
25. Gentile N. Khanna S. Loftus E., Jr Smyrk T. Tremaine W. Harmsen W. et al. (2014) The epidemiology of microscopic colitis in Olmsted County from 2002 to 2010: a population-based study. Clin Gastroenterol Hepatol 12: 838–842.
26. Goldblum J. Wang N. (2000) Lymphocytic and collagenous colitis as possible patterns of Crohn's colitis. Am J Surg Pathol 24: 755–756.
27. Gubbins G. Dekovich A. Ma C. Batra S. (1991) Collagenous colitis: report of nine cases and review of the literature. South Med J 84: 33–37.
28. Günal O. Oktar B. Ozçinar E. Sungur M. Arbak S. Yeðen B. (2003) Estradiol treatment ameliorates acetic acid-induced gastric and colonic injuries in rats. Inflammation 27: 351–359.
29. Gustafsson R. Roth B. Lantz M. Hallengren B. Manjer J. Ohlsson B. (2013) A cross-sectional study of subclinical and clinical thyroid disorders in women with microscopic colitis compared to controls. Scand J Gastroenterol 48: 1414–1422.
30. Henriksen M. Jahnsen J. Lygren I. Sauar J. Schulz T. Stray N. et al. (2006) Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study). Scand J Gastroenterol 41: 1037–1043.
31. Hjortswang H. Tysk C. Bohr J. Benoni C. Kilander A. Larsson L. et al. (2009) Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis 15: 1875–1881.
32. Holstein A. Burmeister J. Plaschke A. Rosemeier D. Widjaja A. Egberts E. (2006) Autoantibody profiles in microscopic colitis. J Gastroenterol Hepatol 21: 1016–1020.
33. Ianiro G. Cammarota G. Valerio L. Annicchiarico B. Milani A. Siciliano M. et al. (2012) Microscopic colitis. World J Gastroenterol 18: 6206–6215.
34. Jarnerot G. Hertervig E. Granno C. Thorhallsson E. Eriksson S. Tysk C. et al. (2001) Familial occurrence of microscopic colitis: a report on five families. Scand J Gastroenterol 36: 959–962.
35. Jarnerot G. Tysk C. Bohr J. Eriksson S. (1995) Collagenous colitis and fecal stream diversion. Gastroenterology 109: 449–455.
36. Jegadeesan R. Liu X. Pagadala M. Gutierrez N. Butt M. Navaneethan U. (2013) Microscopic colitis: is it a spectrum of inflammatory bowel disease? World J Gastroenterol 19: 4252–4256.
37. Jessurun J. Yardley J. Giardiello F. Hamilton S. Bayless T. (1987) Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathologic findings in 15 patients. Hum Path 18: 839–848.
38. Kamada N. Chen G. Inohara N. Núñez G. (2013) Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 4: 685–690.
39. Karatepe O. Altiok M. Battal M. Kamali G. Kemik A. Aydin T. et al. (2012) The effect of progesterone in the prevention of the chemically induced experimental colitis in rats. Acta Cir Bras 27: 23–29.
40. Kochhar R. Patel F. Dhar A. Sharma S. Ayyagari S. Aggarwal R. et al. (1991) Radiation-induced proctosigmoiditis. Prospective, randomized, double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate. Dig Dis Sci 36: 103–107.
41. Koskela R. Karttunen T. Niemela S. Lehtola J. Ilonen J. Karttunen R. (2008) Human leucocyte antigen and TNFalpha polymorphism association in microscopic colitis. Eur J Gastroenterol Hepatol 20: 276–282.
42. La Sala P. Chodosh A. Vecchio J. Schned L. Blaszyk H. et al. (2005) Seasonal pattern of onset in lymphocytic colitis. J Clin Gastroenterol 39: 891–893.
43. Lazenby A. Yardley J. Giardiello F. Jessurun J. Bayless T. (1989) Lymphocytic (“microscopic”) colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Path 20: 18–28.
44. Lee S. Ogilvie R. Dupre M. Gao Z. (2009) Intravascular lymphocytosis in acute appendicitis: potential mimicry of chronic lymphocytic leukaemia. Histopathology 55: 660–664.
45. Leigh C. Elahmady A. Mitros F. Metcalf A. al-Jurf A. (1993) Collagenous colitis associated with chronic constipation. Am J Surg Pathol 17: 81–84.
46. Lindström C. (1976) ‘Collagenous colitis’ with watery diarrhoea – a new entity? Pathol Eur 11: 87–89.
47. Madisch A. Hellmig S. Schreiber S. Bethke B. Stolte M. Miehlke S. (2011) Allelic variation of the matrix metalloproteinase-9 gene is associated with collagenous colitis. Inflamm Bowel Dis 17: 2295–2298.
48. Makinen M. Niemela S. Lehtola J. Karttunen T. (1998) Collagenous colitis and Yersinia enterocolitica infection. Dig Dis Sci 43: 1341–1346.
49. Maxwell J. Gowers I. Moore D. Wilson A. (2010) Alcohol consumption is inversely associated with risk and severity of rheumatoid arthritis. Rheumatology 49: 2140–2146.
50. Meddings J. (1997) Intestinal permeability in Crohn's disease. Alimental Pharmacol Ther 11: 47–53.
51. Miehlke S. Madisch A. Karimi D. Wonschik S. Kuhlisch E. Beckmann R. et al. (2009) Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology 136: 2092–2100.
52. Miehlke S. Madisch A. Voss C. Morgner A. Heymer P. Kuhlisch E. et al. (2005) Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Ther 22: 1115–1119.
53. Moussa L. Bézirard V. Salvador-Cartier C. Bacquié V. Lencina C. Lévêque M. et al. (2012) A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease. PloS ONE 7: e49547.
54. Münch A. Aust D. Bohr J. Bonderup O. Fernandez-Banares F. Hjortswang H. et al. (2012) Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis 6: 932–945.
55. Munck L. Kjeldsen J. Philipsen E. Fischer Hansen B. (2003) Incomplete remission with short-term prednisolone treatment in collagenous colitis: a randomized study. Scand J Gastroenterol 38: 606–610.
56. Nussinson E. Samara M. Vigder L. Shafer I. Tzur N. (1988) Concurrent collagenous colitis and multiple ileal carcinoids. Dig Dis Sci 33: 1040–1044.
57. Olesen M. Eriksson S. Bohr J. Jarnerot G. Tysk C. (2004 a) Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut 53: 536–541.
58. Olesen M. Eriksson S. Bohr J. Jarnerot G. Tysk C. (2004 b) Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993–1998. Gut 53: 346–350.
59. O'Neill S. Yalamarthi S. (2012) Systematic review of the management of ischaemic colitis. Colorectal Dis 14: 751–763.
60. Onishi H. Oosegi T. Machida Y. (2008) Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis. Int J Pharm 358: 296–302.
61. Pardi D. Kelly C. (2011) Microscopic colitis. Gastroenterology 140: 1155–1165.
62. Pardi D. Loftus E. Jr Smyrk T. Kammer P. Tremaine W. Schleck C. et al. (2007) The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut 56: 504–508.
63. Pardi D. Ramnath V. Loftus E. Jr Tremaine W. Sandborn W. (2002) Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol 97: 2829–2833.
64. Parry S. Barton J. Welfare M. (2005) Factors associated with the development of post-infectious functional gastrointestinal diseases: does smoking play a role? Eur J Gastroenterol Hepatol 17: 1071–1075.
65. Patten D. Collett A. (2013) Exploring the immunomodulatory potential of microbial-associated molecular patterns derived from the enteric bacterial microbiota. Microbiology 159: 1535–1544.
66. Perk G. Ackerman Z. Cohen P. Eliakim R. (1999) Lymphocytic colitis: a clue to an infectious trigger. Scand J Gastroenterol 34: 110–112.
67. Pisinger C. Aadahl M. Toft U. Birke H. Zytphen-Adeler J. Jørgensen T. (2011) The association between active and passive smoking and frequent pain in a general population. Eur J Pain 15: 77–83.
68. Rasmussen M. Munck L. (2012) Systematic review: are lymphocytic colitis and collagenous colitis two subtypes of the same disease – microscopic colitis? Aliment Pharmacol Ther 36: 79–90.
69. Read N. Krejs G. Read M. Santa Ana C. Morawski S. Fordtran J. (1980) Chronic diarrhea of unknown origin. Gastroenterology 78: 264–271.
70. Riddell J. Hillman L. Chiragakis L. Clarke A. (2007) Collagenous colitis: oral low-dose methotrexate for patients with difficult symptoms: long-term outcomes. J Gastroenterol Hepatol 22: 1589–1593.
71. Robert M. (2004) Microscopic colitis: pathologic considerations, changing dogma. J Clin Gastroenterol 38(5 Suppl. 1): S18–S26.
72. Roth B. Bengtsson M. Ohlsson B. (2013 a) Diarrhoea is not the only symptom that needs to be treated in patients with microscopic colitis. Eur J Internal Med 24: 573–578.
73. Roth B. Gustafsson R. Jeppsson B. Manjer J. Ohlsson B. (2014) Smoking and alcohol habits in relation to the clinical picture of women with microscopic colitis compared to controls. BMC Women's Health 14: 16.
74. Roth B. Gustafsson R. Ohlsson B. (2013 b) Auto-antibodies and their association with clinical findings in women diagnosed with microscopic colitis. PloS ONE 8: e66088.
75. Roth B. Manjer J. Ohlsson B. (2013 c) Microscopic colitis and reproductive factors related to exposure to estrogens and progesterone. DTI 7: 53–62.
76. Roth B. Manjer J. Ohlsson B. (2013 d) Microscopic colitis is associated with several concomitant diseases. DTI 7: 19–25.
77. Roth B. Ohlsson B. (2013) Gastrointestinal symptoms and psychological well-being in patients with microscopic colitis. Scand J Gastroenterol 48: 27–34.
78. Shim J. (2013) Gut microbiota in inflammatory bowel disease. Pediatr Gastroenterol Hepatol Nutr 16: 17–21.
79. Sjöberg K. Vigren K. Roth B. Malm J. Manjer J. Almquist M. et al. (2013) Vitamin D levels in microscopic colitis. Scand J Gastroenterol 48: 987–988.
80. Stewart M. Seow C. Storr M. (2011) Prednisolone and budesonide for short- and long-term treatment of microscopic colitis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 9: 881–890.
81. Storr M. (2013) Microscopic colitis: epidemiology, pathophysiology, diagnosis and current management – an update 2013. ISRN Gastroenterol 2013: 352718.
82. Teglbjaerg P. Thaysen E. Jensen H. (1984) Development of collagenous colitis in sequential biopsy specimens. Gastroenterology 87: 703–709.
83. Temmerman F. Baert F. (2009) Collagenous and lymphocytic colitis: systematic review and update of the literature. Dig Dis 27(Suppl. 1): 137–145.
84. Teshima C. Dieleman L. Meddings J. (2012) Abnormal intestinal permeability in Crohn's disease pathogenesis. Ann N Y Acad Sci 1258: 159–165.
85. Thijs W. van Baarlen J. Kleibeuker J. Kolkman J. (2005) Microscopic colitis: prevalence and distribution throughout the colon in patients with chronic diarrhoea. Neth J Med 63: 137–140.
86. Thomas P. Forbes A. Green J. Howdle P. Long R. Playford R. et al. (2003) Guidelines for the investigation of chronic diarrhoea, 2nd edition. Gut 52(Suppl. 5): v1–v15.
87. Thörn M. Sjöberg D. Ekbom A. Holmström T. Larsson M. Nielsen A. et al. (2013) Microscopic colitis in Uppsala health region, a population-based prospective study 2005–2009. Scand J Gastroenterol 48: 825–830.
88. Turner J. (2006) Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application. Am J Pathol 169: 1901–1909.
89. Ung K. Gillberg R. Kilander A. Abrahamsson H. (2000) Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut 46: 170–175.
90. Ung K. Kilander A. Nilsson O. Abrahamsson H. (2001) Long-term course in collagenous colitis and the impact of bile acid malabsorption and bile acid sequestrants on histopathology and clinical features. Scand J Gastroenterol 36: 601–609.
91. Vigren L. Sjoberg K. Benoni C. Tysk C. Bohr J. Kilander A. et al. (2011) Is smoking a risk factor for collagenous colitis? Scan J Gastroenterol 46: 1334–1339.
92. Vigren L. Olesen M. Benoni C. Sjoberg K. (2012) An epidemiological study of collagenous colitis in southern Sweden from 2001–2010. World J Gastroenterol 18: 2821–2826.
93. Wagner R. (2008) Effects of microbiota on GI health: gnotobiotic research. Adv Exp Med Biol 635: 41–56.
94. Wang H. Owings D. Antonioli D. Goldman H. (1988) Increased subepithelial collagen deposition is not specific for collagenous colitis. Mod Pathol 1: 329–335.
95. Yen E. Pokhrel B. Du H. New S. Bianchi L. Witt B. et al. (2012) Current and past cigarette smoking significantly increase risk for microscopic colitis. Inflamm Bowel Dis 18: 1835–1841.